SMTL ID : 2viv.1

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.72 Å

Oligo State

monomer

Ligands

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 8 residues within 4Å: Chain A: V.30, C.31, H.46, Y.150, Q.195, G.196, S.198 Ligands: VG2.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Q.195 Hydrogen bonds: A:G.196, A:S.198, A:S.198 Water bridges: A:H.46 Salt bridges: A:H.46

1 x VG2: 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide

VG2.2: 15 residues within 4Å: Chain A: H.46, Y.87, H.94, D.192, S.193, C.194, Q.195, S.198, V.216, W.218, G.219, G.221, C.222, G.229 Ligands: ACT.1 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:Q.195, A:V.216 Hydrogen bonds: A:H.46, A:D.192, A:Q.195

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Frederickson, M. et al., Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator. J.Med.Chem. (2008)

Release Date

2008-01-22

Peptides

UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B

Related Entries With Identical Sequence